The American Journal of Medicine
Volume 122, Issue 10 , Pages 890-895 , October 2009

Hypertension in Pregnancy and Women of Childbearing Age

  • Scott R. Yoder, MD

      Affiliations

    • Department of Internal Medicine, Cardiology Division, University of Rochester Medical Center, Rochester, New York
    • ,
  • Loralei L. Thornburg, MD

      Affiliations

    • Department of Obstetrics and Gynecology, University of Rochester Medical Center, Rochester, New York
    • ,
  • John D. Bisognano, MD, PhD

      Affiliations

    • Department of Internal Medicine, Cardiology Division, University of Rochester Medical Center, Rochester, New York
    • Corresponding Author InformationReprint requests should be addressed to John D. Bisognano, MD, PhD, Associate Professor of Medicine, University of Rochester, Department of Internal Medicine, Cardiology Division, 601 Elmwood Avenue, Box 679-7, Rochester, NY 14642-8679

References 

  1. Chobanian AV, Bakris GL, Black HR, et al. National High Blood Pressure Education Program Coordinating Committee The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560–2572
  2. Cunningham FG, Lindheimer MD. Hypertension in pregnancy. N Engl J Med. 1992;326:927
  3. Sibai , Baha M. Imitators of severe preeclampsia. Obstet Gynecol. 2007;109:956–966
  4. Abalos E, Duley L, Steyn D, Henderson-Smart D. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2007;CD002252
  5. Podymow T, August P. Update on the use of antihypertensive drugs in pregnancy. Hypertension. 2008;51:960–969
  6. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000;183:S1–S22
  7. Gavard JA, Artal R. Effect of exercise on pregnancy outcome. Clin Obstet Gynecol. 2008;51:467–480
  8. Sorensen TK, Williams MA, Lee IM, et al. Recreational physical activity during pregnancy and risk of preeclampsia. Hypertension. 2003;41:1273–1280
  9. Saftlas AF, Logsden-Sackett N, Wang W, et al. Work, leisure-time physical activity, and risk of preeclampsia and gestational hypertension. Am J Epidemiol. 2004;160:758–765
  10. Rudra CB, Williams MA, Lee IM, et al. Perceived exertion during prepregnancy physical activity and preeclampsia risk. Med Sci Sports Exerc. 2005;37:1836–1841
  11. In:  Hacker N,  Moore G editor. Essentials of Obstetrics and Gynecology. 3rd edition. 1998;Chapter 9
  12. In:  Zipes D,  Libby P,  Bonow R,  Braunwald E editor. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 7th edition. 2004;Chapters 73 and 74
  13. In:  Murphy J,  Lloyd M editor. Mayo Clinical Cardiology: Concise Textbook. 3rd edition. 2007;Chapter 62
  14. Helewa ME, Burrows RF, Smith J, et al. Report of the Canadian Hypertension Society Consensus Conference: 1 (Definitions, evaluation and classification of hypertensive disorders in pregnancy). CMAJ. 1997;157:715–725
  15. Brown MA, Hague WM, Higgins J, et al. The detection, investigation and management of hypertension in pregnancy: full consensus statement. Aust N Z J Obstet Gynaecol. 2000;40:139–155
  16. Briggs GG, et al. Drugs in Pregnancy and Lactation. In: 4th ed.. Baltimore: Williams & Wilkins; 1994;p. 161–164
  17. Smith P, Anthony J, Johanson R. Nifedipine in pregnancy. Br J Obstet Gynaecol. 2000;107:299–307
  18. Bortolus R, Ricci E, Chatenoud L, Parazzini F. Nifedipine administered in pregnancy: effect on the development of children at 18 months. BJOG. 2000;107:792–794
  19. Magee LA, Elran E, Bull SB, et al. Risks and benefits of beta-receptor blockers for pregnancy hypertension: overview of the randomized trials. Eur J Obstet Gynecol Reprod Biol. 2000;88:15–26
  20. Walker JJ. Preeclampsia. Lancet. 2000;356:1260–1265
  21. Roberts JM, Cooper DW. Pathogenesis and genetics of preeclampsia. Lancet. 2001;357:53–56
  22. Duley L, Shireen M, Edgardo A. Management of pre-eclampsia. Br Med J. 2006;332:463–468
  23. In:  Creasy RK,  Resnik R,  Iams JD editor. Creasy and Resnick's Maternal-Fetal Medicine: Principles and Practice Sixth Edition. Philadelphia, PA: Saunders Elsevier; 2009;
  24. Brosens IA. Morphological changes in the utero-placental bed in pregnancy hypertension. Clin Obstet Gynaecol. 1977;4:573–593
  25. Roberts JM, Redman CW. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet. 1993;341:1447
  26. Roberts JM, Taylor RN, Musci TJ, et al. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol. 1989;161:1200–1204
  27. Granger JP, Alexander BT, Llinas MT, et al. Pathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction. Microcirculation. 2002;9:147–160
  28. Huppertz B. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension. 2008;51:970–975
  29. Visser N, van Rijn BB, Rijkers GT, et al. Inflammatory changes in preeclampsia: current understanding of the maternal innate and adaptive immune response. Obstet Gynecol Surv. 2007;62:191–201
  30. Yang X, Ramin SM, Kellems RE. Potential roles of angiotensin receptor-activating autoantibody in the pathophysiology of preeclampsia. Hypertension. 2007;50:269–275
  31. Wallukat G, Homuth V, Fischer T, et al. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest. 1999;103:945–952
  32. de Jong CL, Dekker GA, Sibai BM. The renin-angiotensin-aldosterone system in preeclampsia (A review). Clin Perinatol. 1991;18:683–711
  33. Alhenc-Gelas F, Tache A, Saint-Andre JP, et al. The renin-angiotensin system in pregnancy and parturition. Adv Nephrol Necker Hosp. 1986;15:25–33
  34. Adams EM, MacGillivray I. Long-term effect of preeclampsia on blood-pressure. Lancet. 1961;2:1373–1375
  35. Sibai BM, Mercer B, Sarinoglu C. Severe preeclampsia in the second trimester: recurrence risk and long-term prognosis. Am J Obstet Gynecol. 1991;165:1408–1412
  36. Harskaqmp RE, Zeeman GG. Preeclampsia: at risk for remote cardiovascular disease. Am J Med Sci. 2007;334:291–295
  37. Wilson BJ, Watson MS, Prescott GJ, et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. Br Med J. 2003;326:845–851
  38. Castro MA, Fasset MJ, Reynolds TB, et al. Reversible peripartum liver failure: a new perspective on diagnosis, treatment and cause of acute fatty liver of pregnancy based on 28 cases. Am J Obstet Gynecol. 2000;181:389–395
  39. Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk. 8th ed.. Baltimore: Lippincott Williams & Wilkins; 2008;
  40. Schaefer C, Peters PWJ. Drugs During Pregnancy and Lactation. 2nd edition. Academic Press; 2007;

 Funding: None.

 Conflict of Interest: None of the authors have any conflicts of interest associated with the work presented in this manuscript.

 Authorship: All authors had access to the data and played a role in writing this manuscript.

PII: S0002-9343(09)00531-2

doi: 10.1016/j.amjmed.2009.03.036

The American Journal of Medicine
Volume 122, Issue 10 , Pages 890-895 , October 2009

Article Tools